CLDX · Celldex Therapeutics, Inc.
$39.94
-1.76 (-4.22%)
At close · Aug 20
Market Cap
$3.29B
Shares
78.53M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Denice Torres | Director | Appointed | 2026-06-26 |
| Garry A. Neil, M.D. | Director | Appointed | 2026-06-26 |
| James J. Marino | Director | Appointed | 2026-06-26 |
| Rita I. Jain, M.D. | Director | Appointed | 2026-06-26 |
| Herbert J. Conrad | Director | Appointed | 2026-06-26 |
| Cheryl L. Cohen | Director | Appointed | 2026-06-26 |
| Keith L. Brownlie | Director | Appointed | 2026-06-26 |
| Anthony S. Marucci | Chief Executive Officer | Appointed | 2026-06-26 |
| Harry H. Penner, Jr. | Chair of the Board | Appointed | 2026-06-26 |
| Harry H. Penner, Jr. | Chair of the Company's board of directors | Appointed | 2025-06-06 |
| Karen Shoos | board of directors | Terminated | 2025-06-06 |
| Harry H. Penner, Jr. | Director | Appointed | 2024-06-14 |
| Rita I. Jain, M.D. | Director | Appointed | 2024-06-14 |
| James J. Marino | Director | Appointed | 2024-06-14 |
| Garry A. Neil, M.D. | Director | Appointed | 2024-06-14 |
| Keith L. Brownlie | Director | Appointed | 2024-06-14 |
| Herbert J. Conrad | Director | Appointed | 2024-06-14 |
| Cheryl L. Cohen | Director | Appointed | 2024-06-14 |
| Anthony S. Marucci | Chief Executive Officer | Appointed | 2024-06-14 |
| Karen L. Shoos | Chair of the Board | Appointed | 2024-06-14 |
| Rita Jain, M.D. | member of our Board of Directors | Appointed | 2023-02-21 |
| Freddy Jimenez | Senior Vice President and General Counsel | Appointed | 2021-07-01 |
| Elizabeth Crowley | Senior Vice President and Chief Product Development Officer | Appointed | 2021-07-01 |
| Harry H. Penner, Jr. | Director | Appointed | 2021-06-17 |
| James J. Marino | Director | Appointed | 2021-06-17 |
Key facts
CIK
744218
CUSIP
15117B202
13F (30d)
244 filings
239 filers
Visit website
Investor relations